My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 2 results for

GO
Search Filters: New York cancel Utah cancel Pennsylvania cancel New Hampshire cancel New Jersey cancel Population Health and Prevention cancel

How the Emergence of Xylazine Impacts Overdose Prevention Policy

Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Blog,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, withdrawal symptoms, xylazine test strips, ...

Handle with Care: State Newborn Screening Policies

Blog,
Health Policy Update,
Population Health and Prevention,
Women, Infant, and Family Health,
Infant and Child Health,
Policy,
State Health Policy,
Public Health Law,
Arkansas,
California,
Connecticut,
Louisiana,
Maryland,
Massachusetts,
Montana,
New Hampshire,
New Jersey,
New York,
Pennsylvania,
Texas,
Utah,
Wisconsin,
Christina Severin,
Lauren Jones

In the U.S., jurisdictions vary in their newborn screening practices and requirements related to the scope of testing, approach to parental consent, options for blood sample destruction, sample retention periods, and permissible uses of ...